Company / Operating Income
Opus Genetics, Inc. Operating Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$62.1M
FY2025
5-year range
-$62.1M / $18.2M
FY2021-FY2025
Trend
-487.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -488% YoY in FY2025, a notable deviation from the 6-year average annual change of -114%.
Based on SEC 10-K filings.
-$62M in FY2025.
Declined from $18M to -$62M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 487.7% year-over-year.
- Peak operating income was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$62.1M | -487.7% |
| FY2024 | -$10.6M | -158.0% |
| FY2023 | $18.2M | +180.3% |
| FY2022 | -$22.7M | -13.7% |
| FY2021 | -$20.0M | -203.5% |
| FY2013 | -$6.6M | -1.8% |
| FY2011 | -$6.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026